|
ATE234860T1
(de)
*
|
1991-07-13 |
2003-04-15 |
Dade Behring Marburg Gmbh |
Verwendung von hpv-16 e6 und e7-gen gewonnen peptiden für den diagnostischen zweck
|
|
GB9207701D0
(en)
*
|
1992-04-08 |
1992-05-27 |
Cancer Res Campaign Tech |
Papillomavirus e7 protein
|
|
IL105554A
(en)
|
1992-05-05 |
1999-08-17 |
Univ Leiden |
Peptides of human papillomavirus for use in preparations elicit a human T cell response
|
|
GB9306731D0
(en)
*
|
1993-03-31 |
1993-05-26 |
Cancer Res Campaign Tech |
Vaccines
|
|
ATE381624T1
(de)
|
1994-05-09 |
2008-01-15 |
Oxford Biomedica Ltd |
Retrovirale vektoren mit verminderter rekombinationsrate
|
|
US6013517A
(en)
|
1994-05-09 |
2000-01-11 |
Chiron Corporation |
Crossless retroviral vectors
|
|
AUPN015794A0
(en)
|
1994-12-20 |
1995-01-19 |
Csl Limited |
Variants of human papilloma virus antigens
|
|
CA2211995A1
(en)
*
|
1995-02-24 |
1996-08-29 |
Cantab Pharmaceuticals Research Limited |
Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
|
|
AUPN443995A0
(en)
*
|
1995-07-27 |
1995-08-17 |
Csl Limited |
Papillomavirus polyprotein
|
|
WO1998004706A1
(en)
*
|
1996-07-29 |
1998-02-05 |
Cantab Pharmaceuticals Research Limited |
Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
|
|
GB9717953D0
(en)
|
1997-08-22 |
1997-10-29 |
Smithkline Beecham Biolog |
Vaccine
|
|
DE19925199A1
(de)
*
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
|
DE19925235A1
(de)
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
|
AU2007201619B2
(en)
*
|
1999-09-16 |
2011-05-12 |
Eisai Inc. |
Nucleic acids encoding polyepitope polypeptides
|
|
JP2003509035A
(ja)
*
|
1999-09-16 |
2003-03-11 |
ザイコス インク. |
ポリエピトープポリペプチドをコードする核酸
|
|
US8128922B2
(en)
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
WO2002012281A2
(en)
|
2000-08-03 |
2002-02-14 |
Johns Hopkins University |
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
|
|
CN1694958A
(zh)
*
|
2002-09-13 |
2005-11-09 |
昆士兰大学 |
以密码子翻译效率为基础的基因表达系统
|
|
US9701725B2
(en)
|
2003-05-05 |
2017-07-11 |
The Johns Hopkins University |
Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
AU2005322960A1
(en)
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
RNA interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by DNA and transfected dendritic cell vaccines
|
|
EP1846026A4
(en)
*
|
2005-01-26 |
2008-07-02 |
Univ Johns Hopkins |
ANTIBODY DNA VACCINE WITH PLASMIDES FOR CODING A MUTATED ONCOPROTEIN ANTIGEN AND CALRETICULIN
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
US8426163B2
(en)
|
2007-12-07 |
2013-04-23 |
National Health Research Institutes |
Production of lipidated proteins in E. coli
|
|
US8466259B2
(en)
|
2007-12-07 |
2013-06-18 |
National Health Research Institutes |
Adjuvants
|
|
US8287880B2
(en)
|
2009-06-02 |
2012-10-16 |
National Health Research Institutes |
Lipidated vaccine against dengue virus infection
|
|
US8658176B2
(en)
|
2009-06-22 |
2014-02-25 |
National Health Research Institutes |
Lipidated tumor-associated antigens and immunotherapeutic compositions
|
|
TW201221642A
(en)
|
2010-11-15 |
2012-06-01 |
Nat Health Research Institutes |
Method of producing lipidated polypeptides
|
|
TWI507413B
(zh)
|
2010-11-15 |
2015-11-11 |
Nat Health Research Institutes |
脂質化多抗原表位疫苗
|
|
KR102216962B1
(ko)
*
|
2011-10-12 |
2021-02-18 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
인간 파필로마 바이러스에 대한 백신 및 이것을 사용하는 방법
|
|
US10232030B2
(en)
|
2013-03-12 |
2019-03-19 |
Inovio Pharmaceuticals, Inc. |
Vaccines for human papilloma virus and methods for using the same
|
|
KR20170121301A
(ko)
*
|
2015-03-18 |
2017-11-01 |
옴니사이트 |
변형된 알파 바이러스 표면 당 단백질 및 종양-관련 항원을 포함하는 융합 단백질 및 이의 방법
|
|
CA3066779A1
(en)
*
|
2017-06-28 |
2019-01-03 |
Regeneron Pharmaceuticals, Inc. |
Anti-human papillomavirus (hpv) antigen-binding proteins and methods of use thereof
|